Exact claim · Version 1 · Reviewed 2026-07-23
“All products called CJC-1295 are interchangeable.”
A verdict on this wording and scope, not a universal grade for CJC-1295.
01 · Verdict
Misleading
The literature and commercial market may refer to different molecular forms, salts, modifications, and combinations.
- Evidence basis
- Regulatory or product record
- Scope
- Products marketed as CJC-1295 with different forms, salts, modifications, combinations, or quality controls.
- Category
- Product equivalence
02 · Primary record
Check the attached evidence
01CJC-1295 pharmacy compounding advisory reviewU.S. Food and Drug Administration · FDA review · 2024
Supports the corrective verdict02Certain bulk drug substances that may present significant safety risksU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict
Supports the corrective verdict02Certain bulk drug substances that may present significant safety risksU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.